Literature DB >> 19549591

Signaling inputs to progesterone receptor gene regulation and promoter selectivity.

Andrea R Daniel1, Todd P Knutson, Carol A Lange.   

Abstract

Progesterone receptors (PR) select and control genetic programs in the breast during normal mammary gland development, and progestin-driven processes contribute to the initiation and/or progression of breast cancer [Beral, V., 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419-427; Chlebowski, R.T., Hendrix, S.L., Langer, R.D., Stefanick, M.L., Gass, M., Lane, D., Rodabough, R.J., Gilligan, M.A., Cyr, M.G., Thomson, C.A., et al., 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289, 3243-3253]. Throughout the mammalian life span, progesterone exerts varying biological consequences on the mammary epithelial compartment, from brief proliferative spurts that occur with each luteal phase of the menstrual cycle to the massive expansion of the pregnant gland in preparation for lactation [Brisken, C., Park, S., Vass, T., Lydon, J.P., O'Malley, B.W., Weinberg, R.A., 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 95, 5076-5081; Ismail, P.M., Amato, P., Soyal, S.M., DeMayo, F.J., Conneely, O.M., O'Malley, B.W., Lydon, J.P., 2003. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68, 779-787]. These processes, while important developmentally, can become deregulated in breast cancer, thereby contributing to unchecked proliferation, increased survival, and invasive behaviors. Recently, our lab has focused on the molecular mechanisms, including phosphorylation events, by which PRs select specific target genes in response to progestins and other mitogenic hormonal signals (i.e. EGF, heregulin). Herein, we discuss the actions of cytoplasmic signaling molecules such as c-Src and mitogen-activated protein kinases as key mediators of PR promoter selectivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549591      PMCID: PMC3924551          DOI: 10.1016/j.mce.2009.01.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  47 in total

1.  Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.

Authors:  Andrew Skildum; Emily Faivre; Carol A Lange
Journal:  Mol Endocrinol       Date:  2004-10-14

2.  Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300.

Authors:  G I Owen; J K Richer; L Tung; G Takimoto; K B Horwitz
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

3.  Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene.

Authors:  L G Hudson; K L Thompson; J Xu; G N Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  A paracrine role for the epithelial progesterone receptor in mammary gland development.

Authors:  C Brisken; S Park; T Vass; J P Lydon; B W O'Malley; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

Authors:  Nick Z Lu; John A Cidlowski
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

6.  Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.

Authors:  Britta M Jacobsen; Stephanie A Schittone; Jennifer K Richer; Kathryn B Horwitz
Journal:  Mol Endocrinol       Date:  2004-11-24

7.  Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1.

Authors:  Sumie Kato; Mauricio Pinto; Andrés Carvajal; Natalia Espinoza; Carolina Monso; Anil Sadarangani; Manuel Villalon; Jan J Brosens; John O White; Jennifer K Richer; Kathryn B Horwitz; Gareth I Owen
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

8.  Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.

Authors:  A Migliaccio; D Piccolo; G Castoria; M Di Domenico; A Bilancio; M Lombardi; W Gong; M Beato; F Auricchio
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

9.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.

Authors:  Kathryn B Horwitz; Wendy W Dye; Joshua Chuck Harrell; Peter Kabos; Carol A Sartorius
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

View more
  31 in total

1.  ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.

Authors:  Christy R Hagan; Tarah M Regan; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

2.  The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.

Authors:  Andrea R Daniel; Angela L Gaviglio; Lauren M Czaplicki; Christopher J Hillard; Daniel Housa; Carol A Lange
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 3.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

4.  Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.

Authors:  Maria Loreto Bravo; Mauricio P Pinto; Ibeth Gonzalez; Barbara Oliva; Sumie Kato; Mauricio A Cuello; Carol A Lange; Gareth I Owen
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

5.  Differential and interactive effects of ligand-bound progesterone receptor A and B isoforms on tyrosine hydroxylase promoter activity.

Authors:  P J Jensik; L A Arbogast
Journal:  J Neuroendocrinol       Date:  2011-10       Impact factor: 3.627

Review 6.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

Review 7.  Role of phosphorylation in progesterone receptor signaling and specificity.

Authors:  Christy R Hagan; Andrea R Daniel; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Endocrinol       Date:  2011-09-16       Impact factor: 4.102

8.  The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.

Authors:  Lindsey S Treviño; William E Bingman; Dean P Edwards; Weigel Nl
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

9.  Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.

Authors:  Suzanne E Wardell; Ramesh Narayanan; Nancy L Weigel; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2009-12-11

10.  Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.

Authors:  Caroline H Diep; Todd P Knutson; Carol A Lange
Journal:  Mol Cancer Res       Date:  2015-11-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.